Latest Us Market News

Medical Developments International (ASX:MVP) reported a 9% revenue increase to $42.6 million and a 566% jump in net profit to $0.6 million for FY26, driven by robust growth in its Pain Management segment and expanded paediatric approvals in Europe.

Zip Co Limited (ASX: ZIP) reported a 46% rise in net profit to $116.4 million for FY26, driven by strong US and ANZ market growth and record cash earnings of $268.9 million. The company also announced an orderly wind down of its New Zealand operations to focus on its core markets.

ReNerve Ltd (ASX:RNV) reported an 80% year-on-year revenue increase in Q4 FY26, backed by expanding product lines and a $5 million funding facility. The company is advancing FDA approvals and growing its global distribution footprint, targeting a rapidly expanding $6.19 billion nerve repair biomaterials market.

ImpediMed has secured FDA 510(k) clearance for its SOZO Digital Health Platform to assess sarcopenia risk, marking it as the only FDA-cleared bioimpedance spectroscopy solution for this clinical application. This clearance enables clinicians to non-invasively monitor muscle loss in cancer and chronic disease patients, potentially improving treatment outcomes.

ION Video has appointed two seasoned executives to its board and elevated Anthony Baker to Managing Director as it sharpens focus on scaling its patented video technology. Founder Finbar O’Hanlon steps back from the board to concentrate on innovation and expanding the company’s IP portfolio.

OD6 Metals is moving to list its shares on the US OTCQB Venture Market to tap growing North American investor interest and highlight its high-grade Quinn Fluorspar Project in Nevada, a critical mineral asset in a 100% import-dependent US market.

The Environmental Group Limited (ASX:EGL) posted flat revenue of $112 million for FY26 but saw a sharp 44.7% fall in EBITDA and a $6 million net loss, weighed down by operational disruptions, a major ERP system implementation, and a $3 million goodwill impairment.

Wagners Holding Company Limited (ASX:WGN) reported a 17% revenue increase to $504 million and a 78.5% surge in net profit after tax to $40.6 million for FY26, driven by strong growth in Construction Materials and Composite Fibre Technologies.

Pro Medicus delivered a robust FY26 with 28% underlying revenue growth, a surge in new contract wins worth $407 million, and a 25% increase in fully franked dividends, underpinned by strong AI product development and rapid implementations.

Carbonxt has completed delivery of all replacement kiln parts at its Kentucky activated carbon facility and is on track for construction completion this quarter. The company also increased its investment in NewCarbon Processing, raising its stake to 49.4%.

OncoSil Medical has won FDA Humanitarian Device Exemption approval for its OncoSil™ device to treat distal cholangiocarcinoma, opening a US market estimated at A$80 million annually.

Nodestream has engaged Waypoint Strategic Partners to provide hands-on leadership and operational support for its US market entry, marking a shift from assessment to active execution under its Plan Consilience defence strategy.